Enricoso, Bb Boy .
HRN: 21-26-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFTAZIDIME 1GM (VIAL)
06/16/2022
06/22/2022
IV
50mg
Q8
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes